Table 3.
One-Person Technique | |||||||||
Beginner
(N = 34) |
Intermediate
(N = 34) |
Expert
(N = 34) |
p-Value | ||||||
Initial cecal intubation rate | 91.2% (31/34) | 97.1% (33/34) | 100% (34/34) | 1.00 | |||||
Cecal insertion time (s) | 479.5 ± 222.2 | 410.7 ± 167.3 | 342.4 ± 213.5 | 0.03 | |||||
Total procedure time (s) | 1656.6 ± 719.1 | 1421.9 ± 892.4 | 1201.6 ± 478.7 | 0.04 | |||||
Adenoma detection rate | 20.6% (7/34) | 29.4% (10/34) | 41.2% (14/34) | 0.03 | |||||
Propofol | 95.2 ± 41.6 | 89.3 ± 32.7 | 83 ± 25.6 | 0.39 | |||||
Midazolam | 3.77 ± 1.24 | 3.58 ± 1.04 | 3.38 ± 1.29 | 0.37 | |||||
Pethidine | 30.6 ± 8.0 | 27.5 ± 6.5 | 26.1 ± 5.6 | 0.54 | |||||
Additional sedative administration frequency | 2.6 ± 1.9 | 2.3 ± 1.2 | 1.9 ± 1.1 | 0.19 | |||||
Complications | 6 (17.6%) | 3 (8.8%) | 1 (3%) | 0.45 | |||||
Recovery time | 48.1 ± 21.2 | 45.0 ± 9.2 | 40.2 ± 20.0 | 0.39 | |||||
Patient pain score | 2.72 ± 2.03 | 2.34 ± 1.57 | 2.11 ± 1.34 | 0.04 | |||||
FACIT-F by endoscopist | 45.6 ± 12.8 | 36.9 ± 9.2 | 27.9 ± 8.1 | <0.001 | |||||
Two-person technique | |||||||||
Beginner
(N = 34) |
Intermediate
(N = 34) |
Expert
(N = 34) |
p-value | ||||||
Initial cecal intubation rate | 94.1% (32/34) | 94.1% (32/34) | 100% (34/34) | 0.50 | |||||
Cecal insertion time (s) | 414.8 ± 252.4 | 386.7 ± 161.3 | 345.2 ± 86.0 | 0.06 | |||||
Total procedure time (s) | 1393.0 ± 513.9 | 1286.2 ± 858.8 | 1210.3 ± 276.1 | 0.10 | |||||
Adenoma detection rate | 38.2% (13/34) | 35.2% (12/34) | 29.4% (10/34) | 0.58 | |||||
Propofol | 81.1 ± 48.5 | 78.5 ± 47.5 | 77.9 ± 28.0 | 0.25 | |||||
Midazolam | 3.37 ± 1.48 | 3.20 ± 0.82 | 3.12 ± 1.27 | 0.37 | |||||
Pethidine | 27.6 ± 3.6 | 24.5 ± 5.7 | 23.5 ± 4.3 | 0.58 | |||||
Additional sedative administration frequency | 2.3 ± 1.4 | 1.80 ± 1.2 | 1.6 ± 0.8 | 0.43 | |||||
Complications | 4 (11.8%) | 1 (2.9%) | 2 (5.8%) | 0.11 | |||||
Recovery time | 40.1 ± 18.5 | 37.0 ± 22.2 | 34.3 ± 11.4 | 0.07 | |||||
Patient pain score | 2.35 ± 1.60 | 2.19 ± 1.47 | 1.91 ± 1.47 | 0.08 | |||||
FACIT-F by endoscopist | 25.2 ± 10.3 | 23.2 ± 9.3 | 20.0 ± 7.4 | 0.58 | |||||
Beginner | Intermediate | Expert | |||||||
OPT
(N = 34) |
TPT
(N = 34) |
p -value |
OPT
(N = 34) |
TPT
(N = 34) |
p -value |
OPT
(N = 34) |
TPT
(N = 34) |
p -value | |
Initial cecal intubation rate | 91.2% (31/34) | 94.1% (32/34) | 0.64 | 97.1% (33/34) | 94.1% (32/34) | 0.55 | 100% (34/34) | 100% (34/34) | 1.00 |
Cecal insertion time (s) | 479.5 ± 222.2 | 414.8 ± 252.4 | 0.27 | 410.7 ± 167.3 | 386.7 ± 161.3 | 0.54 | 342.4 ± 213.5 | 345.2 ± 86.0 | 0.94 |
Total procedure time (s) | 1656.6 ± 719.1 | 1393.0 ± 513.9 | 0.09 | 1421.9 ± 892.4 | 1286.2 ± 858.8 | 0.53 | 1201.6 ± 478.7 | 1210.3 ± 276.1 | 0.92 |
Adenoma detection rate | 20.6% (7/34) | 38.2% (13/34) | 0.11 | 29.4% (10/34) | 35.2% (12/34) | 0.27 | 41.2% (14/34) | 29.4% (10/34) | 0.31 |
Propofol | 95.2 ± 41.6 | 81.1 ± 48.5 | 0.02 | 89.3 ± 32.7 | 78.5 ± 47.5 | 0.02 | 83 ± 25.6 | 77.9 ± 28.0 | 0.04 |
Midazolam | 3.77 ± 1.24 | 3.37 ± 1.48 | 0.04 | 3.58 ± 1.04 | 3.20 ± 0.82 | 0.10 | 3.38 ± 1.29 | 3.12 ± 1.27 | 0.40 |
Pethidine | 30.6 ± 8.0 | 27.6 ± 3.6 | 0.06 | 27.5 ± 6.5 | 24.5 ± 5.7 | 0.10 | 26.1 ± 5.6 | 23.5 ± 4.3 | 0.22 |
Additional sedative administration frequency | 2.6 ± 1.9 | 2.3 ± 1.4 | 0.46 | 2.3 ± 1.2 | 1.80 ± 1.2 | 0.09 | 1.9 ± 1.1 | 1.6 ± 0.8 | 0.20 |
Complications | 6 (17.6%) | 4 (11.8%) | 0.49 | 3 (8.8%) | 1 (2.9%) | 0.30 | 1 (3%) | 2 (5.8%) | 0.35 |
Recovery time | 48.1 ± 21.2 | 40.1 ± 18.5 | 0.01 | 45.0 ± 9.2 | 37.0 ± 22.2 | 0.02 | 40.2 ± 20.0 | 34.3 ± 11.4 | 0.04 |
Patient pain score | 2.72 ± 2.03 | 2.35 ± 1.60 | 0.02 | 2.34 ± 1.57 | 2.19 ± 1.47 | 0.04 | 2.11 ± 1.34 | 1.91 ± 1.47 | 0.55 |
FACIT-F by endoscopist | 45.6 ± 12.8 | 25.2 ± 10.3 | <0.001 | 36.9 ± 9.2 | 23.2 ± 9.3 | <0.001 | 27.9 ± 8.1 | 20.0 ± 7.4 | <0.001 |
Values are n (%) or mean ± SD. OPT, one-person technique; TPT, two-person technique; FACIT-F, Functional Assessment of Chronic Illness Therapy Fatigue.